» Articles » PMID: 26866596

Nanotopography-Induced Structural Anisotropy and Sarcomere Development in Human Cardiomyocytes Derived from Induced Pluripotent Stem Cells

Overview
Date 2016 Feb 12
PMID 26866596
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Understanding the phenotypic development of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) is a prerequisite to advancing regenerative cardiac therapy, disease modeling, and drug screening applications. Lack of consistent hiPSC-CM in vitro data can be largely attributed to the inability of conventional culture methods to mimic the structural, biochemical, and mechanical aspects of the myocardial niche accurately. Here, we present a nanogrid culture array comprised of nanogrooved topographies, with groove widths ranging from 350 to 2000 nm, to study the effect of different nanoscale structures on the structural development of hiPSC-CMs in vitro. Nanotopographies were designed to have a biomimetic interface, based on observations of the oriented myocardial extracellular matrix (ECM) fibers found in vivo. Nanotopographic substrates were integrated with a self-assembling chimeric peptide containing the Arg-Gly-Asp (RGD) cell adhesion motif. Using this platform, cell adhesion to peptide-coated substrates was found to be comparable to that of conventional fibronectin-coated surfaces. Cardiomyocyte organization and structural development were found to be dependent on the nanotopographical feature size in a biphasic manner, with improved development achieved on grooves in the 700-1000 nm range. These findings highlight the capability of surface-functionalized, bioinspired substrates to influence cardiomyocyte development, and the capacity for such platforms to serve as a versatile assay for investigating the role of topographical guidance cues on cell behavior. Such substrates could potentially create more physiologically relevant in vitro cardiac tissues for future drug screening and disease modeling studies.

Citing Articles

Engineering the 3D structure of organoids.

Moss S, Bakirci E, Feinberg A Stem Cell Reports. 2024; 20(1):102379.

PMID: 39706178 PMC: 11784486. DOI: 10.1016/j.stemcr.2024.11.009.


Matrix Architecture and Mechanics Regulate Myofibril Organization, Costamere Assembly, and Contractility in Engineered Myocardial Microtissues.

DePalma S, Jilberto J, Stis A, Huang D, Lo J, Davidson C Adv Sci (Weinh). 2024; 11(47):e2309740.

PMID: 39558513 PMC: 11653763. DOI: 10.1002/advs.202309740.


Induced pluripotent stem cell-derived cardiomyocyte in vitro models: benchmarking progress and ongoing challenges.

Ewoldt J, DePalma S, Jewett M, Karakan M, Lin Y, Mir Hashemian P Nat Methods. 2024; 22(1):24-40.

PMID: 39516564 DOI: 10.1038/s41592-024-02480-7.


Lab-on-a-chip models of cardiac inflammation.

Popovic A, Lei M, Shakeri A, Khosravi R, Radisic M Biomicrofluidics. 2024; 18(5):051507.

PMID: 39483204 PMC: 11524635. DOI: 10.1063/5.0231735.


Reprogramming stem cells in regenerative medicine.

Mao J, Saiding Q, Qian S, Liu Z, Zhao B, Zhao Q Smart Med. 2024; 1(1):e20220005.

PMID: 39188749 PMC: 11235200. DOI: 10.1002/SMMD.20220005.


References
1.
Engler A, Carag-Krieger C, Johnson C, Raab M, Tang H, Speicher D . Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating. J Cell Sci. 2008; 121(Pt 22):3794-802. PMC: 2740334. DOI: 10.1242/jcs.029678. View

2.
Konhilas J, Irving T, de Tombe P . Frank-Starling law of the heart and the cellular mechanisms of length-dependent activation. Pflugers Arch. 2002; 445(3):305-10. DOI: 10.1007/s00424-002-0902-1. View

3.
Gherghiceanu M, Barad L, Novak A, Reiter I, Itskovitz-Eldor J, Binah O . Cardiomyocytes derived from human embryonic and induced pluripotent stem cells: comparative ultrastructure. J Cell Mol Med. 2011; 15(11):2539-51. PMC: 3822963. DOI: 10.1111/j.1582-4934.2011.01417.x. View

4.
Macadangdang J, Lee H, Carson D, Jiao A, Fugate J, Pabon L . Capillary force lithography for cardiac tissue engineering. J Vis Exp. 2014; (88). PMC: 4188383. DOI: 10.3791/50039. View

5.
Solouk A, Cousins B, Mirahmadi F, Mirzadeh H, Jalali Nadoushan M, Shokrgozar M . Biomimetic modified clinical-grade POSS-PCU nanocomposite polymer for bypass graft applications: a preliminary assessment of endothelial cell adhesion and haemocompatibility. Mater Sci Eng C Mater Biol Appl. 2014; 46:400-8. DOI: 10.1016/j.msec.2014.10.065. View